​

Dr. Lina Dahabiyeh, Dr. Shereen Aleidi, and Dr. Yasser Bustanji participated in DUPHAT 2025 held from January 7–9, 2025, at the World Trade Center in Dubai, UAE.

Dr. Shereen and Dr. Yasser delivered oral presentations showcasing the application of metabolomics in biomarker discovery. Dr. Shereen's presentation, titled “Untargeted Metabolomic Profiling of Gestational Diabetes Mellitus: Insights into Early Diagnosis and Metabolic Pathway Alterations," highlighted advancements in early diagnosis and metabolic pathway analysis for gestational diabetes. Dr. Yasser's presentation, titled “Metabolomic Profiling in Obesity: Insights into Diagnostic Biomarkers and Metabolic Pathway Alterations," provided key findings on diagnostic biomarkers and metabolic changes associated with obesity.

The Dubai International Pharmaceuticals & Technologies Conference and Exhibition (DUPHAT) is a premier event in the pharmaceutical and healthcare sectors, attracting professionals, researchers, and industry leaders from around the globe. It serves as a platform for sharing knowledge, innovations, and advancements in pharmaceutical sciences, with a focus on education, networking, and collaboration.​